SURGICAL TREATMENT METHODS FOR NON-ALCOHOLIC FATTY LIVER DISEASE
https://doi.org/10.34822/2304-9448-2021-3-8-13
Abstract
The study aims to analyze scientific literature devoted to the bariatric surgery effect on the non-alcoholic fatty liver disease, to identify patterns and determinants of the effect made, to formulate a theory of optimization of the treatment algorithm for the non-alcoholic fatty liver disease in patients with obesity. Material and methods. In the course of the study, the scientific literature on the topic of the effect of bariatric surgery on the fatty liver disease was searched in the following databases: Springer, Pubmed, IFSO, Google Scholar. The search included articles written both in English and in Russian, which were published starting from 2015. The keywords used: bariatric surgery effect on the non-alcoholic fatty liver disease, bariatric surgery and non-alcoholic fatty liver disease, mechanisms of the bariatric surgery effect on the non-alcoholic fatty liver disease, methods of treatment for the non-alcoholic fatty liver disease, NAFLD, bariatric surgery and NAFLD, non-alcoholic fatty liver, methods of treatment NAFLD. Results. The non-alcoholic fatty liver disease can be a factor allowing to expand the indications for bariatric surgery performance to the patients with 1-2 stages of obesity, according to the scientific literature review. It is obvious that a solid evidence ground based on additional experimental and practical materials and randomized clinical trials is required for the introduction of such an algorithm of treatment into everyday practice.
About the Authors
A. A. Shapilov
Surgut State University;
Surgut Municipal Clinical Hospital, Surgut
Russian Federation
Russian Federation
Postgraduate, Department of Surgical Diseases, Medical Institute;
Surgeon
E-mail: shopil348@gmail.com
S. V. Onishchenko
Surgut State University;
Surgut Regional Clinical Hospital, Surgut
Russian Federation
Russian Federation
Doctor of Sciences (Medicine), Associate Professor, Department of Surgical Diseases, Medical Institute;
Oncologist
E-mail: sergej-on@mail.ru
V. R. Tutolmin
Surgut Regional Clinical Hospital, Surgut
Russian Federation
Russian Federation
Surgeon
References
1. Вовк Е. И. Неалкогольная жировая болезнь печени как проатерогенное заболевание: диагностика и лечение в общей практике // Мед. обозрение. 2017. № 2. С. 68–79.
2. Дедов И. И., Мельниченко Г. А., Шестакова М. В., Трошина Е. А., Мазурина Н. В. и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-й пересмотр (Лечение морбидного ожирения у взрослых) // Ожирение и метаболизм. 2018. Т. 15, №. 1. С. 53–70. DOI 10.14341/OMET2018153-70.
3. Ивашкин В. Т., Маевская М. В., Павлов Ч. С., Тихонов И. Н., Широкова Е. Н. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации // Рос. журнал гастроэнтерологии, гепатологии, колопроктологии. 2016. № 2. С. 24–41.
4. Younossi Z. M., Koenig A. B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes // Hepatology. 2016. Vol. 64, Is. 1. Р. 73–84. DOI 10.1002/hep.28431.
5. Ицкова Е. А., Крючкова О. Н., Лутай Ю. А., Турна Э. Ю., Жукова Н. В. Основные положения Национальных клинических рекомендаций по диагностике, лечению, профилактике ожирения и ассоциированных с ним заболеваний // Крымский терапевтический журнал. 2018. № 4. С. 5–11.
6. Ding L., Oligschlaeger Y., Shiri-Sverdlov R., Houben T. Nonalcoholic fatty liver disease // Handbook of Experimental Pharmacology. 2020. DOI 10.1007/164_2020_352.
7. Щеголев А. И., Туманова У. Н., Мишнёв О. Д. Факторы риска развития гепатоцеллюлярной карциномы // Междунар. журнал прикладных и фундаментальных исследований. 2018. № 9. С. 164–169.
8. Leung C. et al. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease // World Journal of Gastroenterology. 2015. Vol. 21, Is. 4. Р. 1189–1196. DOI 10.3748/wjg.v21.i4.1189.
9. Цуканов В. В., Васютин А. В., Тонких Ю. Л. Современные принципы ведения пациентов с неалкогольной жировой болезнью печени // Доктор.Ру. 2019. № 3 (158). С. 11–14. DOI 10.31550/1727-2378-2019-158-3-11-14.
10. Мирчук К. К., Василевский Д. И., Анисимова К. А., Давлетбаева Л. И. Метаболические эффекты бариатрических операций // Педиатр. 2019. Т. 10, № 2. С. 99–109. DOI: https://doi.org/10.17816/PED10299-109.
11. Talavera-Urquijo E., Beisani M., Balibrea J. M., Alverdy J. C. Is bariatric surgery resolving NAFLD via microbiotamediated bile acid ratio reversal? A comprehensive review // Surg Obes Relat Dis. 2020. Vol. 16, Is. 9. P. 1361–1369. DOI 10.1016/j.soard.2020.03.013.
12. Sberna A., Bouillet B., Rouland A., Brindisi M.-C., Nguyen A., Mouillot T., Duvillard L. et al. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease // Diabetic Medicine. 2018. Vol. 35, № 3. DOI 10.1111/ dme.13565.
13. Chitturi Sh. et al. The Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017- Part 2: Management and special groups // Journal of gastroenterology and hepatology. 2018. Vol. 33, Is. 1. P. 86–98. DOI 10.1111/jgh.13856.
14. Chalasani N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases // Hepatology. 2018. Vol. 67, Is. 1. P. 328–357. DOI 10.1002/ hep.29367.
15. Agarwal L. et al. Bariatric surgery in nonalcoholic fatty liver disease (NAFLD): impact assessment using paired liver biopsy and fibroscan // Obesity surgery. 2016. Vol. 31, Is. 2. P. 617–626. DOI 10.1007/s11695-020-04977-4.
16. Guillaume L. et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients // Gastroenterology. 2015. Vol. 149, Is. 2. P. 379–838. DOI 10.1053/j.gastro.2015.04.014.
17. Salman M. A., Salman A. A., Abdelsalam A. et al. Laparoscopic sleeve gastrectomy on the horizon as a promising treatment modality for NAFLD // Obes Surg. 2020. Vol. 30, Is. 1. P. 87–95. DOI 10.1007/s11695-019-04118-6.
18. Aguilar-Olivos N. E., Almeda-Valdes P., Aguilar-Salinas C. A., Uribe M., Mendez-Sanchez N. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome // Metabolism. 2016. Vol. 65, Is. 8.P. 1196–1207.
19. Pooler B. D. et al. Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center study // Radiology. 2019. Vol. 290, Is. 3. Р. 682–690. DOI 10.1148/radiol.2018181134.
20. Hedderich D. M., Hasenberg T., Haneder S., Schoenberg S. O., Kücükoglu Ö., Canbay A., Otto M. Effects of bariatric surgery on non alcoholic fatty liver disease: magnetic resonance imaging is an effective, non-invasive method to evaluate changes in the liver fat fraction // Obes Surg. 2017. Vol. 27, Is. 7. Р. 1755–1762. DOI 10.1007/s11695-016-2531-3.
21. Yeo S. C., Ong W. M., Cheng K. S. A. et al. Weight loss after bariatric surgery predicts an improvement in the nonalcoholic fatty liver disease (NAFLD) fibrosis score // Obes Surg. 2019. Vol. 29, Is. 4. P. 1295–1300. DOI 10.1007/ s11695-018-03676-5.
22. Фишман М. Б., Карев В. Е., Ван Я., Соколова Д. А., Мицинская А. И., Мицинский М. А. Метаболическая хирургия в коррекции жировой болезни печени // Вестник хирургии им. И. И. Грекова. 2017. № 176 (1). С. 34–41. DOI: https://doi.org/10.24884/0042-4625-2017-176-1-34-41.
Review
For citations:
Shapilov A.A., Onishchenko S.V., Tutolmin V.R. SURGICAL TREATMENT METHODS FOR NON-ALCOHOLIC FATTY LIVER DISEASE. Vestnik SurGU. Meditsina. 2021;(3 (49)):8-13. (In Russ.) https://doi.org/10.34822/2304-9448-2021-3-8-13
Views:
196
Email this article 
